Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency

Clinical trial NCT01704079 · COMPLETED

Trial details

NCT number: NCT01704079
Sponsor: OPKO IP Holdings II, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Disease Hyperparathyroidism, Secondary Vitamin D Deficiency

Start date: 2012-11-01
Primary completion: 2014-08-01
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.